When the HaCaT cells were treated with PTX + CIS, we found a 1- to 3-fold increase in MCL-1 gene and > 2.5-fold in NOXA, BAD, P65/RELA, PUMA and BCL-XL. The gene discussed is PMAIP1; the disease is in situ carcinoma.